Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
Nitromed |
---|---|
Information provided by: | Nitromed |
ClinicalTrials.gov Identifier: | NCT00047775 |
A placebo-controlled trial of BiDil added to standard therapy in African-American patients with heart failure.
Condition | Intervention | Phase |
---|---|---|
Congestive Heart Failure |
Drug: BiDil |
Phase IV |
Study Type: | Interventional |
Study Design: | Treatment, Randomized, Double-Blind, Placebo Control, Single Group Assignment, Safety/Efficacy Study |
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
United States, Alabama | |
Cooper Green Hospital | |
Birmingham, Alabama, United States, 35233 | |
United States, Arkansas | |
Cardiology and Medicine Clinic | |
Little Rock, Arkansas, United States, 72204 | |
United States, District of Columbia | |
Howard University Hospital | |
Washington, District of Columbia, United States, 20060 | |
United States, Florida | |
Miami International Cardiology Consultants | |
Aventura, Florida, United States, 33180 | |
United States, Massachusetts | |
Boston Medical Center | |
Boston, Massachusetts, United States, 02118 | |
United States, Minnesota | |
Minneapolis VA Medical Center | |
Minneapolis, Minnesota, United States, 55417 | |
United States, New York | |
Saint Vincents Hospital and Medical Center | |
New York, New York, United States, 10011 |
Study Chair: | Anne L. Taylor, M.D. | University of Minnesota |
Study ID Numbers: | A-HeFT |
Study First Received: | October 18, 2002 |
Last Updated: | June 23, 2005 |
ClinicalTrials.gov Identifier: | NCT00047775 |
Health Authority: | United States: Food and Drug Administration |
Heart Failure Heart Diseases |
Cardiovascular Diseases |